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Abstract
Background: Individual skeletal elements of the vertebrate limbs arise through a segmentation process introducing
joints in specific locations. However, the molecular pathways controlling joint formation and subsequent joint
maintenance are largely unknown. In this study, we focused on SOX11, and its contribution to the regulation of
GDF5, a secreted signal necessary for proper joint formation and postnatal joint homeostasis.
Results: Sox11 is initially expressed broadly in the murine cartilage condensations at early stages of skeletal
development, but its expression is specifically increased in the forming joint interzone as is forms. SOX11
overexpression can directly activate GDF5 expression both in vitro and in micromass cell cultures prepared from
chick limb buds. Conserved SOX family binding sites are present in the 5’ UTR region of the GDF5 gene and we
show SOX11 can specifically bind to one of them. While misexpression of Sox11 in developing chick limbs through
RCAS virus infection does not induce Gdf5 expression in ectopic locations, it does enhance its expression. To
explore the roles of Sox11 in joint homeostasis, we analyzed adult knee joints in an osteoarthritis mouse model
where the medial meniscus and the medial collateral ligament were removed. We also analyzed knee joints from
human subjects who underwent total knee replacement surgery. We find that SOX11 is mainly expressed in the
weight-bearing areas of knee joints, and its expression is decreased in degraded cartilage during progression of
knee osteoarthritis in both mice and humans.
Conclusions: This work implicates SOX11 as a potential regulator of GDF5 expression in joint maintenance and
suggests a possible role in the pathogenesis of osteoarthritis.
Keywords: SOX11, GDF5, Joint maintenance, Articular cartilage
Background
Within the embryonic limb, skeletal development is
initiated by aggregation of mesenchymal cells. These early
condensations can subsequently adopt either of two dis-
tinct fates. They can give rise to cartilage and then bone
through a process known as an endochondral ossification
[1] or alternatively they can initiate a program leading to
joint formation. In this latter process, a localized dense re-
gion known as an interzone is formed in the mesenchymal
condensations, ultimately yielding a synovium, a capsule,
ligaments and articular cartilage [2]. Although the molecu-
lar mechanisms regulating endochondral ossification have
been fairly well-investigated [3,4], those controlling joint
formation largely remain to be clarified. The subsequent
mechanisms of joint maintenance are equally poorly
understood.
Osteoarthritis (OA) is one of the most common diseases
of the joint, which is characterized by cartilage destruction,
synovial inflammation, and bone remodeling. Since articu-
lar cartilage has very poor regenerative capability, once the
joint surface becomes degraded, it cannot be recovered.
OA is a multifactorial disease which is influenced by me-
chanical, environmental and genetic factors [5,6].
GDF5 is one of the genes that has been implicated in
joint maintenance. Gdf5 is expressed in the early develo-
ping joint interzone [7], and loss-of-function mutations in
this gene cause abnormalities of a number of joints in
mice [7,8]. However, misexpression of Gdf5 does not
induce ectopic joints, but rather causes an increase in
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estingly, GDF5 has also been reported to be required for
joint integrity and homeostasis in humans. A single nu-
cleotide polymorphism in the human GDF5 promoter that
reduces its transcriptional activity is associated with
susceptibility to osteoarthritis [5]. Moreover, human loss-
of-function mutations in the GDF5 gene result in congeni-
tal skeletal disorders such as Hunter-Thompson and
Grebe chondrodysplasia [12].
SOX genes are involved in cell type specification in a
variety of tissues, including sex determination, neuro-
genesis and skeletal formation [13]. Of particular rele-
vance, the chondrocyte lineage is established through
the activity of SOX9, SOX5 and SOX6 [4,14]. SOX9 binds
to a regulatory element of the cartilage-specific type II
collagen (COL2A1) gene [15], and its mutation in
humans is known to cause a skeletal malformation called
campomelic dysplasia [16,17]. Interestingly, the chon-
drogenic actions of SOX genes are also required for syn-
ovial joint morphogenesis [18], raising the possibility
that SOX genes might similarly play integral roles in
joint maintenance.
Based on analysis of their HMG domains, SOX genes
can be separated into subgroups A-J [19]. Here, we
examined the group-C SOX gene SOX11. We find that
Sox11 is expressed in the cartilage condensations in early
stages of skeletal development in mice, but at later
stages Sox11 expression is notably increased in the joint
interzone. We show that SOX11 can activate GDF5 ex-
pression and demonstrate that there is a direct binding
site for SOX11 in the 5’UTR of the GDF5 gene in vitro.
Sox11 misexpression in chicks does not induce ectopic
joint formation in vivo, but slightly enhances endoge-
nous Gdf5 expression. Finally, we find that SOX11 pro-
tein levels are decreased in degraded cartilage during
osteoarthritic progression in humans and mice, indica-
ting a possible role of SOX11 in pathogenesis of
osteoarthritis.
Results
The Sox11 expression in developing limbs
To identify candidate genes that might play a role in
regulating GDF5 expression in developing joints, we
conducted a preliminary screen of all the known SOX
transcription factors. We examined the transcriptional
activities of a reporter dependent upon the human
GDF5 promoter (−448/+319) following overexpression
of each of the known human SOX genes in Hela and
ATDC5 cells (Additional file 1). The genes that gave the
most prominent results in this assay were the three
group-C SOX genes (SOX4, SOX11, and SOX12) and of
these, SOX11 produced the strongest enhancement in
both cell lines. The increased luciferase activitities
induced by co-transfection of SOX11 and the reporter
construct containing the GDF5 promoter were about 18
and 3.5 times higher (in the two cell lines respectively)
than that of SOX11 and the control reporter vector lack-
ing the GDF5 promoter but containing the luciferase
reporter (Additional file 1). We noted that SOX11
activated transcription in the absence of the GDF5
promoter, albeit to a lesser degree, presumably due to
non-specific interactions with the backbone of the re-
porter plasmid. This effect, which was not specific to
SOX11, might be caused by the more stable α-helical
structure of its transactivation domain than other SOX
genes [20]. Nonetheless, SOX11 had a clear and signifi-
cant effect on the GDF5 promoter above that seen with
the vector alone. On the other hand, the overexpression
of SOX6 and 9, which are known to be involved in car-
tilage differentiation in developing limb, had less effect
on the activity of the GDF5 promoter than that of
SOX11. Based on this preliminary screen, we chose
SOX11 for further study.
We first compared the expression pattern of Sox11 and
Gdf5 by double fluorescence section in situ hybridization
during an embryonic limb development of mice. At
embryonic stage 13.5 (E13.5), when joint interzones are
just starting to form between the metatarsals and tarsal
elements, Sox11 is expressed in the cartilage condensa-
tions, showing a distinct expression pattern from the
joint-specific Gdf5 (Figure 1). However, at E14.5, the level
of Sox11 transcription is specifically increased at the inter-
zone in the prospective joint region and co-localized with
Gdf5 (Figure 1).
Increase of endogenous GDF5 expression by SOX11
overexpression
To examine the capacity of SOX11 to regulate cellular
GDF5 expression, we created variants of the murine
chondrogenic ATDC5 and fibroblastic C3H10T1/2 cell
lines in which we stably introduced human SOX11
through retroviral infection. The resultant SOX11 over-
expression increased endogenous mRNA levels of Gdf5
in both cell lines (Figure 2A). Conversely, the Gdf5
mRNA level was suppressed (to a level 44% of that seen
in controls) by the retrovirally mediated shRNA knock-
down of endogenous Sox11 activity (to a level 12% of
that seen in controls) in ATDC5 cells (Figure 2B).
SOX11 has three conserved domains: an N-terminus
SRY-related HMG domain (amino acids 1–125), an acid-
rich domain (amino acids 218–250) and a C-terminus
domain (amino acids 386–441) (Additional file 2), which
contains potential transcriptional regulatory regions [21].
To determine the domains that are required for GDF5
expression, we created constructs lacking each domain,
called SOX11ΔN (lacks amino acid 1–134), SOX11ΔAR
(lacks amino acid 200–309) and SOX11ΔC (lacks amino
acid 297–441), respectively, and examined their ability
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lack of the N-terminus HMG domain or C-terminus do-
main abrogated the transcriptional response induced by
full-length SOX11 overexpression (Additional file 3A).
Moreover, the endogenous Gdf5 mRNA level was signifi-
cantly suppressed by constructs carrying deletions in
either of these domains in ATDC5 cells by retroviral in-
fection (Additional file 3B). In contrast, the construct
lacking the acid-rich domain did not abrogate Gdf5
expression (Additional file 3B), indicating that the
N-terminus and C-terminus domains, but not the acid-
rich domain, play important roles in mediating SOX11
function with respect to GDF5 expression.
Identification of a core SOX11-responsive element in the
GDF5 promoter
We found five clustered sequences similar to the puta-
tive SOX family consensus binding site (A/T)(A/T)CAA
(A/T)G in this region (Figure 2C), that were highly con-
served between humans and mice [22]. One of them was
one-base different from the published consensus binding
site (shaded in dark gray), and the others were two-bases
different (shaded in light gray) (Figure 2C). We created
four reporter constructs deleting these motifs: deletion
of first two binding sites (+151 bp and +214 bp), first
three binding sites (+151 bp and +229bp), first four
binding sites (+151 bp and +247 bp), or all five binding
sites (+151 bp and +276 bp); and compared their tran-
scriptional activities in a dual-luciferase assay. We
observed a stepdown in the luciferase activity induced
when a deletion is introduced between +215 bp and
+247 bp, which contains two adjacent SOX family bin-
ding motifs. These were thus candidates for SOX11
binding sites in the GDF5 promoter. A 49 bp element
(+209 bp/+257 bp), containing the identified putative
binding sites, was defined as segment A (Figure 2D).
To further determine the core responsive sequence in
segment A, we created mutations in the identified motifs
(mutation 1 at +222 bp, mutation 2 at both +222 bp and
+224 bp, mutation 3 at both +222 bp and +228 bp, mu-
tation 4 at +238 bp, mutation 5 at both +238 bp and
+240 bp, and mutation 6 at both +238 bp and +244 bp).
Transactivation by SOX11 was decreased only by muta-
tions 4,5 and 6, not by mutations 1,2 or 3, and the
inhibitory effect among mutations 4, 5 and 6 were com-
parable, indicating that the thymine at the +238 bp
nucleotide is crucial for the binding between GDF5 pro-
moter and SOX11 (Figure 2D).
Previous reports suggest that a single nucleotide
polymorphism (SNP) rs143383 (+45 bp) in the 5’UTR
region is related to GDF5 expression and its postnatal
joint maintenance [5]. We found a putative SOX fam-
ily binding motif at (+57/+63) just downstream of the
SNP. We examined the potential ability of SOX11 to
activate gene transcription through this motif in a
luciferase assay. Deletion of the SOX motif near the
SNP did decrease transcriptional activity induced by
SOX11 overexpression. However, the one nucleotide
mutation at the +238 bp (identified above) suppressed
it more extensively, indicating the binding motif at
+238 has a stronger affinity for the GDF5 promoter
(Additional file 4).
Sox11 Gdf5 DAPI Merge
Sox11 Gdf5 DAPI Merge
E13.5
E14.5
Figure 1 Expression patterns of Sox11 and Gdf5 during joint formation in mouse embryos. Double fluorescence section section in situ
hybridization in hind limbs of mouse embryos (E13.5, 14.5). Confocal microscope images show (from left to right): Sox11 (red channel), GDF5
(green channel), DAPI staining of nuclei, and merged images. White arrowheads indicate the location of the interzone at prospective joint sites.
Scale bars, 200 μm.
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Figure 2 (See legend on next page.)
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ment A in electromobility shift (EMSA) and chromatin
immunoprecipitation (ChIP) assays. In EMSA, an oligo-
nucleotide probe detected a complex formation between
a segment A and in-vitro translated SOX11 protein,
which was supershifted by an antibody to SOX11, indi-
cating the direct binding of SOX11 to the segment A
(Figure 3A). Moreover, cold competition with an excess
amount of the unlabeled wild-type probe reduced the
complex formation. Specificity of SOX11 antibody was
confirmed by the absence of a supershift band with a
non-immune normal IgG (Additional file 5). A chroma-
tin immunoprecipitation (ChIP) assay was performed
using HeLa cells transfected with SOX11 linked to three
tandem repeats of the HA tag. Pull down with an anti-
body to the HA tag showed in vivo binding of SOX11 to
the GDF5 regulatory region including segment A
(Figure 3B). Specificity was confirmed, as SOX11 was
not immunoprecipitated by the overexpression of the
empty vector or by a control non-immune IgG antibody.
Involvement of SOX11 in cartilage formation in vitro
GDF5 is known to have chondrogenic ability in vitro
and in vivo [9-11]. Therefore, we next examined the
potential ability of SOX11 to stimulate chondrogenic
differentiation in vitro. The endogenous mRNA levels
of chondrogenic marker genes, Col2a1, Sox6 and
TenascinC [23] were all increased by the retroviral intro-
duction of human SOX11 into ATDC5 cells (Figure 4A).
Moreover, a short hairpin RNA (shRNA) directed
against the endogenous mouse Sox11 decreased the
expression of the three chondrogenic marker genes
(Figure 4A). A similar chondrogenic effect of SOX11 was
observed in micromass cell cultures of chick limb bud
cells after infection of an RCAS virus encoding human
SOX11, as indicated by an increase in Alcian blue
staining (Figure 4B). The endogenous Gdf5 mRNA level
was concomitantly increased in the micromass cultures
by the infection of RCAS virus encoding SOX11
(Figure 4B).
Misexpression of Sox11 in chicks enhances Gdf5
expressions in vivo
To know the effect of Sox11 overexpression in vivo,w e
injected RCAS virus encoding GFP fused to the chick
Sox11 cDNA into right chick lateral plate mesoderm at
HH stage 10 (day 1.5), and harvested the limb at HH
stage 32 or 35 (day 7.5 or 8.5, respectively). After con-
firming GFP fluorescence (Figure 4C), we performed
whole mount in situ hybridization on the injected limbs
with a riboprobe for chick Gdf5. We used the non-
infected contralateral side of the same embryo as a con-
trol. Misexpression of Sox11 did not induce additional
domains of Gdf5 expression, indicating Sox11 is not suf-
ficient to drive its expression in ectopic locations
(Figure 4C). However, when we harvested the hind limbs
and examined the expression level of Gdf5, we saw a
slight but significant enhancement following Sox11
overexpression (Figure 4D). The increased expression of
GDF5 protein was also confirmed by Western blotting
(Figure 4E). These results suggest that Sox11 can at least
partially contribute to the regulation of Gdf5 expression
but it is more than likely that there are other molecules
involved in its expression during embryonic development.
Decrease of SOX11 expression during cartilage
degradation
To know the role of SOX11 in cartilage homeostasis, we
next created an experimental osteoarthritis (OA) model
through surgical induction of instability in the knee
joints of 8-week-old mice [24]. Sox11 is normally
expressed at a high level in the weight-bearing regions of
the mature joint, although it is less expressed in the per-
ipheral weight bearing zone or non-weight bearing zone
such as edge of femoral condyle, tibial plateau or inter-
condylar space (Additional file 6). Four weeks after
surgery, the medial knee joints exhibited cartilage
degradation, as demonstrated by a decrease in Safranin-
O staining (Figure 5). Immunohistochemical analysis
revealed that both Sox11 and Gdf5 expression levels
were decreased in the degraded cartilage in the medial
knee joint, whereas they were still strongly expressed in
(See figure on previous page.)
Figure 2 Determination of a core responsive element of SOX11 in the GDF5 promoter. (A) Levels of Gdf5 mRNA in ATDC5 and C3H10T1/2
cells retrovirally transfected with the control vector (Rx-EV) or the vector expressing human SOX11 (Rx-SOX11). mRNA levels were determined by
quantitative RT-PCR, normalized to Gapdh, and expressed as means (bars)±SDs (error bars) for 4 wells/construct. *P<0.05 vs. Rx-EV. (B) Gdf5 and
Sox11 mRNA levels in ATDC5 cells retrovirally transfected with the shRNA vector targeting GFP (Rx-shGFP) or targeting mouse Sox11 (Rx-shSox11).
*P< 0.05 vs. Rx-shGFP. (C) Deletion analysis using constructs lacking putative SOX-family-binding motifs in the proximal human GDF5 promoter
(+151/+276) in ATDC5, C3H10T1/2, and HeLa cells. Five putative SOX family binding sites are shown (+159 to +165, +179 to +185, +222 to +228,
+238 to +244, +258 to +264). The site with 1 base difference from the ideal binding site is shaded in dark gray, and those with 2 bases difference
are indicated in light gray. Luciferase assays were carried out as above, in ATDC5, C3H10T1/2 and HeLa cells. *P<0.05 vs. deletion of +151/+214
**P< 0.05 vs. deletion of +151/+229. (D) Identification of a core responsive element of SOX11 in the GDF5 promoter (segment A: +209/+257).
Site-directed mutagenesis analysis with 6 mutated constructs (M1–M6). Base changes for each mutation as shown. Luciferase assays were carried
out as above, in ATDC5, C3H10T1/2 and HeLa cells. The data for the luciferase assay are expressed as means (bars)± SDs (error bars) of Relative
luciferase activity for 4 assays/construct. *P<0.05 vs. wild type promoter, –448/+319.
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from the lateral knee joint of OA-operated knees
(Figure 5A) (Additional file 7). These results were con-
sistent among multiple sections obtained from the cen-
ter of the weight-bearing area in different mouse knee
joints (n = 6/6 slides) (Figure 5A).
Finally we analyzed 10 samples of human knee joints
that had undergone total knee arthroplasty. Immunohis-
tochemical analysis revealed that SOX11 expression was
decreased from early stages of osteoarthritis progression,
as assessed by decreased Safranin-O staining and modi-
fied Mankin’s cartilage degradation scores (Figure 5B)
(Additional file 8). Specificity of SOX11 antibody was
confirmed by using the antibody of non-immune IgG
(Additional file 9).
Discussion
In the present study, we identify SOX11 as a molecule
contributing to the regulation of GDF5 expression du-
ring joint formation and maintenance. In previous stu-
dies, SOX11 was identified as an essential molecule for
neuronal maturation, however its molecular function in
developing limbs had not been explored [25,26]. We
found that SOX11 is expressed in the skeletal elements
of the developing limbs and that its expression is
increased in joint tissue as it develops (Figure 1). Sox11
Competitor
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Figure 3 Direct binding between SOX11 protein and GDF5 promoter. (A) Electro mobility shift assay (EMSA) for binding of the wild-type
(WT) and mutated probes with human SOX11 protein. An open arrowhead indicates the shifted bands of the SOX11-DNA probe complex, and a
solid arrowhead indicates the band super shifted by an antibody to SOX11. Cold competitions with a 50-fold excess of the unlabeled WT probe
or the mutated probes are shown. Detailed information about each mutated nucleotide is indicated in Figure 2D. (B) Chromatin
immunoprecipitation (ChIP) assay for in vivo binding of SOX11 and the segment A. Cell lysates of HeLa cells transfected with empty vector (3xHA
EV) or SOX11 (3xHA SOX11) were amplified with a primer set (+98/+364) spanning segment A.
Kan et al. BMC Developmental Biology 2013, 13:4 Page 6 of 12
http://www.biomedcentral.com/1471-213X/13/4Col2a1
Rx-SOX11 Rx-EV
0
A Sox6
Rx-SOX11 Rx-EV
Tnc
Rx-SOX11 Rx-EV
(x102)
0
1
2
5
C
o
p
i
e
s
 
/
 
n
g
t
o
t
a
l
 
R
N
A
0
50
0
(x102)
2
1
Rx-shSox11 Rx-shGFP
0
6
4
2
Rx-shSox11 Rx-shGFP Rx-shSox11 Rx-shGFP
0
50
B
C
o
p
i
e
s
 
/
 
n
g
t
o
t
a
l
 
R
N
A
Gdf5
0
10
SOX11
0
50
RCAS-EV RCAS-SOX11 RCAS-EV RCAS-SOX11
Col2a1 Sox6 Tnc
* * *
#
# #
* *
C
HH32 
(E7.5)
HH35 
(E8.5)
Gdf5
GFP
D
0
Gdf5
30
Injected Control
C
o
p
i
e
s
 
/
 
n
g
t
o
t
a
l
 
R
N
A
*
Injected Control
Sox11
(x103)
0
4
Injected Control
*
GDF5
ACTB
E
1 0.94
1 1.47
1 1.56
GDF5/         
ACTB
RCAS-EV RCAS-SOX11
Injected Control
Figure 4 Contribution of Sox11 to Gdf5 expression in developing limbs. (A) mRNA levels of Col2a1, Sox6 and TenasinC (Tnc) in ATDC5 cells
that were retrovirally transfected with a control vector (Rx-EV) or human SOX11 (Rx-SOX11) and the short hairpin RNA directed against GFP (Rx-
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and SOX11 in those cultures after infection of RCAS virus encoding human SOX11. *P<0.05 vs. RCAS-EV. (C) Whole mount in situ hybridization for
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HH stage 10. The GFP fluorescence after the injection is also shown. Red arrows indicate the injected right hind limbs, while white arrows
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35 (E8.5) after the RCAS injection of GFP-fused chick Sox11. The uninjected left hind limb is used as control. *P<0.05 vs. control. (E) Western
blotting for Gdf5 and β-Actin (ACTB) in HH stage 35 (E8.5) chick hind limbs after the RCAS injection of GFP-fused chick Sox11. The uninjected left
hind limb is used as control. The GFP fluorescence in the embryos used for Western blotting analysis is also shown. Red arrow indicates the
injected hind limb and white arrow shows the control hind limb. Densitometric analysis was performed with Image J software.
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abnormalities [27]. However, no defects were observed
in the program of joint formation per se, and the resul-
ting limb phenotype is not severe [27]. It is more than
likely that many genes are involved in joint formation
and their function may be redundant.
We show that SOX11 can enhance GDF5 expression
in vitro (Figure 2). SOX proteins are known to bind the 5’
UTR of target genes to modulate their transcriptional ac-
tivities. [28,29] We find that, indeed, SOX11 can bind the
5’UTR of the GDF5 gene. Although SOX11 enhanced
chondrogenic proliferation in vitro, its misexpression
in vivo did not affect the gross morphology of limb nor
the mRNA expression patterns of Gdf5 (Figure 4C). How-
ever, SOX11 overexpression increased the mRNA levels of
Gdf5 both in micromass cell culture from chick limb bud
cells and in misexpression experiments in vivo,a l b e i tt oa
small extent (Figure 4). While SOX11 is not requisite for
joint formation, our results suggest that SOX11 is likely to
at least partially contribute to the regulation of GDF5
expression during that process.
Finally, to investigate the roles of SOX11 in joint
homeostasis, we examined its expression pattern in an
osteoarthritis experimental model of knee joints in adult
mice and human samples after total knee replacement
surgery (Figure 5). A single nucleotide polymorphism in
the GDF5 gene has been reported to be related to sus-
ceptibility to osteoarthritis [5,30]. Although the SOX11
binding site in our study seems to be independent of this
reported SNP, reverse phase protein arrays in osteoarth-
ritic and normal cartilage tissue identified SOX11 as one
of the molecules down-regulated in osteoarthritic
Sham Osteoarthritis
Safranin-O
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A B
2
Cartilge degradeation
(Modified Mankin Score)
Safranin-O
HE
-SOX11
61 0
Medial (Op.) Lateral Medial (Op.) Lateral
-SOX11
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Figure 5 Contribution of SOX11 to articular cartilage homeostasis in mice and humans. (A) Histological findings of articular cartilage after
creating an experimental osteoarthritis model that induces instability in the knee joints of 8-week-old mice. HE and Safranin-O stainings, as well
as immunohistochemical staining with an antibody to SOX11 (α-SOX11) or GDF5 (α-GDF5) were performed 4 weeks after surgery. A sham
operation was performed using the same approach. Operations were performed in the medial side of knee joints. Dotted line highlights the
region where Safranin-O staining is lost in the arthritic model. Red arrowheads indicate positive signal for SOX11 or GDF5. Scale bars, 500 μm. (B)
H&E staining, Safranin-O staining and immunostaining with an antibody to human SOX11 in human knee cartilages, obtained as surgical
specimens of total knee arthroplasty. Cartilage degradation was evaluated by the modified Mankin scoring system. The blue and red side bars
indicate the articular cartilage layer and subchondral bone layer, respectively. Scale bars, 500μm.
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pression was decreased in degraded cartilage both in
mouse experimental osteoarthritis model and in human
samples of osteoarthritis. These data support the specu-
lation that SOX11 could be important not only for em-
bryonic joint formation, but also for joint homeostasis in
articular cartilage in adults. This could be tested by
assessing whether Sox11 deficient mice have increased
incidence of developing OA relative to their wild type
littermates.
Joint formation is a complex and multistep process. An-
other molecule essential for joint formation is Wnt9a [32].
Wnt signaling inhibits chondrogenesis and promotes joint
formation [32,33]. Several joints are abnormally formed in
the Wnt9a-deficient mice [34]. The process of joint forma-
tion likely includes local induction of β-catenin/Wnt9a
activity, which serves to block chondrogenesis and to sub-
sequently maintain the interzone space. In parallel, signals
secreted from the interzone, potentially including Gdf5,
act on neighboring cartilage elements to prevent induction
of a new interzone in the vicinity. Cells taken from pro-
spective autopod joint sites using a microsurgical proce-
dure displayed a propensity to undergo chondrogenesis
following treatment with exogenous recombinant Gdf5
[35], indicating that the formation of the mature articular
cartilage is induced by the stimulation of chondrogenesis
by secreted proteins such as Gdf5.W es u g g e s tt h a tSOX11
could be one of the molecules involved in the later stages
of joint development, contributing to the maturation of
articular cartilage, at least in part through enhancing
GDF5 expression.
Conclusions
In this study, we have identified SOX11 as being capable
of directly regulating GDF5 in vitro and showed its par-
tial contribution to the in vivo regulation of GDF5
expression during joint formation and homeostasis. The
further identification of molecules acting upstream of
GDF5 will not only provide further understanding of
joint formation, but will also potentially lead to insight
into the pathogenesis of human joint diseases such as
osteoarthritis.
Methods
Animals
All animal experiments were performed according to a
protocol approved by the Institutional Animal Care and
Use Committee (IACUC) at Harvard Medical School
and the Animal Care and Use Committee of the Univer-
sity of Tokyo.
Cell cultures
DF-1 cells were obtained from the American Type Cul-
ture Collection (ATCC), and ATDC5, C3H10T1/2, and
HeLa cells were obtained from the RIKEN BioResource
Center Cell Bank (Ibaraki, Japan). DF-1, C3H10T1/2 and
HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% FBS (Invitro-
gen, Carlsbad, CA), supplemented with L-glutamine
(2 mM), penicillin (100 U/mL), and streptomycin (100
mg/mL). ATDC5 cells were maintained in DMEM/
Ham’s F-12 (1:1) containing 5% FBS, human transferrin
(10 μg/mL), sodium selenite (30 nM) and the above
supplements.
Plasmid construction
The human SOX11 gene was PCR-amplified, and cloned
into pCMV-HA plasmid (Clontech, Mountain View, CA).
The SOX11 cDNA was then excised from pCMV-HA and
cloned into pMx-IRES-Bsr retroviral expression plasmid
[36] and pCMV-3x HA tag vector, which was modified
from the original pCMV-3Tag-1A vector (Stratagene,
La Jolla, CA). Human GDF5 cDNA was cloned into the
pMx-IRES-Bsr. Chick Sox11 cDNA was cloned into the
pCAG-GFP vector [37], and chick cDNA with GFP frag-
ment was excised and cloned into RCAS-BP(A) vector
[38]. The deleted mutants of the functional domains in
SOX11 were created by PCR. For gene silencing, short
hairpin RNA (shRNA) sequences directed against the
mouse Sox11 gene and GFP for control were designed by
BLOCK-iT RNAi Designer (Invitrogen) and their expres-
sion vectors were constructed with piGENEmU6 vector
(iGENE Therapeutics, Tokyo). The U6 promoter and the
insert were excised from the piGENEmU6 and cloned into
the pMx-IRES-Bsr. The 5’-flanking sequence (−448 bp/
+319 bp) of the human GDF5 promoter was amplified by
PCR and cloned into pGL3-basic plasmid (Promega,
Madison, WI). Mutated constructs were created by PCR.
Sequences of all the plasmids were confirmed by an ABI
PRISM 3100-Avant Genetic Analyzer (Applied Biosys-
tems, Foster City, CA). Primers for plasmid construction
and shRNA design are shown in Additional file 10.
Luciferase assay
Transfection of ATDC5, C3H10T1/2, or HeLa cells was
performed in duplicate in 24-well plates using FuGene 6
with plasmid DNA (200 ng of pGL3 reporter vector, 100
ng of effector vector and 4 ng of pRL-TK vector
(Promega) for internal control per well). Cells were
harvested 48 hours after transfection. Luciferase assays
were performed with a dual luciferase reporter assay sys-
tem (Promega) using the LMax luminometer (Molecular
Devices, Sunnyvale, CA). Results were shown as the
ratio of firefly activity to Renilla activity. Four wells were
transfected with each construct (2 wells for Figure S1)
and experiments were repeated at least twice in each cell
line for each construct.
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Two x 10
6 Plat-E cells were plated in 60-mm dishes, and
were transfected with 3 μg pMx vector using Fugene
(Roche) on the following day. Forty-eight hours after
transfection, the medium was collected and used as the
retrovirus supernatant, which was applied to the ATDC5
or C3H10T1/2 cells. Selection of the retrovirally intro-
duced ATDC5 or C3H10T1/2 cells was started after 2
days in the medium containing 10 μg/ml of blasticidin.
After 2 weeks, the surviving cells were collected and
assayed.
Quantitative RT-PCR analysis
Total RNAs from cells were isolated with an RNeasy
Mini Kit (Qiagen) and each sample was treated by
DNase, reverse-transcribed with a QuantiTect reverse
transcription kit (Qiagen), and used as a template for the
2nd step PCR. Full-velocity SYBR Green PCR Master
Mix (Stratagene, La Jolla, CA) was used for the 2nd step
PCR and fluorescence detection was performed with
MX3000P (Stratagene). Copy numbers of target genes’
mRNA were quantified by a dilution series of standard
templates and adjusted with human, rodent or chick
Gapdh as an internal control. Four pipetting replicates
were performed for each reaction. Primers for quatitative
RT-PCR are shown in Additional file 10.
Electrophoretic mobility shift assay (EMSA)
SOX11 protein was in-vitro translated using the TNT
Quick coupled transcription/translation system (Promega).
EMSA was carried out using a DIG Gel Shift kit (Roche),
according to manufacturer’s instructions. Binding reactions
were incubated for 30 minutes at room temperature. For
competition analyses, a 50-fold excess of unlabeled com-
petitor probe was included in the binding reaction. For the
super shift experiments, 200ng of anti-SOX11 antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) was added
after 30 minutes of binding reaction, and the reaction
was incubated for an additional 60 minutes at room
temperature. Samples were loaded onto Novex 6%
Tris–borate–EDTA gels (Invitrogen) and electrophoresed
at 120V for 60 minutes.
Chromatin immunoprecipitation (ChIP) assay
A ChIP assay was performed with an OneDay ChIP kit,
according to manufacturer’s instructions (Diagenode,
Liege, Belgium). HeLa cells were transfected with 3x HA
tagged empty vector or the SOX11 vector using FuGene
6 as described above. In vivo crosslinking was performed
72 hours after transfection. To shear genomic DNA, the
lysates were then sonicated on ice ten times for 30 sec-
onds each. For immunoprecipitation, 1μg of anti-HA
antibody (Abcam, Cambridge, MA) or non-immune nor-
mal rabbit IgG were used.
Histological analyses of mouse embryos
For section in situ hybridization, partial coding sequences
of mouse Sox11 and Gdf5 gene with the T7 promoter
sequence were obtained by PCR amplification. A labeled
antisense riboprobe for Sox11 was prepared with T7 RNA
polymerase using a DIG RNA labeling mix (Roche), and
that for Gdf5 was prepared using a Fluorescein RNA
labeling mix (Roche). The C57BL/6 mouse embryos
(E13.5-E14.5) were prepared as previously described [39].
The Sox11 probe was detected using an anti-DIG anti-
body-coupled POD and TSA plus cyanine 3 system
(PerkinElmer, Waltham, MA). The Gdf5 probe was
detected using an anti-Fluorescein antibody-coupled POD
and TSA plus Fluorescein system (PerkinElmer). Images
were obtained using an SP2 inverted confocal microscope
(Leica, Wetzlar, Germany). For immunohistochemistry,
tissues were fixed in 4% paraformaldehyde, embedded in
paraffin. The sections were incubated with primary
antibodies to SOX11 (Sigma; 1:200) or GDF5 (Abcam;
1:100). Immunodetection was performed using CSA II
(DakoCytomation, Carpinteria, CA).
Misexpression experiment in chick embryos
A chicken fibroblast cell line DF-1 was plated in a 60
mm dish the day before transfection. Three μgo fR C A S
BP (A) plasmids were introduced with Fugene6 transfec-
tion regent (Roche). The cells were cultured for 3 weeks,
and the supernatant was collected and used as a virus
stock. Preparation of micromass cell culture and the in-
fection of RCAS virus were performed as previously
described [32]. The RCAS viruses were injected into the
lateral plate mesoderm of Hamburger Hamilton (HH)
stage 10 chick embryos (day 1.5) to target gene misex-
pression to developing limbs as previously reported
[38,40]. Embryos were harvested at HH stage 32 or 35
(or day 7.5, 8.5, respectively). Tissue preparations for
whole mount in situ hybridization were performed as
described above. Digoxigenin (DIG)-labeled antisense
riboprobes were detected using anti-DIG antibody-
coupled AP and NBT/BCIP solution (Roche). For quati-
tative RT-PCR analysis, total RNAs from chick limbs at
HH stage 35 were isolated with an RNeasy Mini Kit. For
Western blotting, hind limbs of HH stage 35 were
homogenized with TissueLyser (Qiagen). Anti-GDF5
antibody (Abcam; 1:1000) and Anti-β-Actin antibody
(Abcam; 1:1000) were used for primary antibodies and
Goat anti-Rabbit antibody (Jackson ImmunoResearch;
1:10000) was used for a secondary antibody. Densito-
metry analysis was performed with ImageJ software.
Osteoarthritis experiment
The surgical procedure to create an osteoarthritis ex-
perimental model of knee joints was carried out as pre-
viously reported [24], transecting the medial collateral
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sham operation was performed on the contralateral knee.
Four weeks after surgery, the entire knee joints were dis-
sected, decalcified, and underwent hematoxylin-eosin
(HE) and Safranin-O-fast green stainings, and/or immu-
nohistochemical staining with the antibody to SOX11 and
GDF5.
Human samples
We obtained human samples from individuals undergo-
ing total knee arthroplasty after obtaining written
informed consent as approved by the Ethics Committee
of the University of Tokyo. We histologically assessed
cartilage degradation according to the modified Mankin
scoring system. [41,42].
Statistical analysis
A Mann-Whitney test was performed for the statistical
analyses of luciferase assays and quantitative RT-PCR.
p<0.05 was deemed significant.
Additional files
Additional file 1: Figure S1. Screening for candidate SOX genes
activating GDF5 promoter. Luciferase assays for the transcriptional activity
of the GDF5 promoter by the overexpression of different SOX family
molecules in ATDC5 and HeLa cells transfected with GDF5 promoter
region (−448/+319) ligated to the luciferase-reporter gene. Data are
expressed as means (bars) ± SDs (error bars) of Relative luciferase activity
for two assays/construct. EV: empty vector, the vector containing the
luciferase transgene but lacking the GDF5 promoter.
Additional file 2: Figure S2. Conserved domains in the SOX11 protein
sequence among humans, mice and chicks. Amino acid sequences
coding SOX11 protein is shown and the conserved domains among
species are indicated by black boxes.
Additional file 3: Figure S3. Identification of functional SOX11
domains which are required for GDF5 expression. (A) Luciferase assays for
the transcriptional activity of the reporter driven by the GDF5 (−448/
+319) promoter, in the context of co-transfection with deletion mutants
that lack N-terminus domain (Rx-ΔN), Acid-rich domain (Rx-ΔAR), or C-
terminus domain (Rx-ΔC) in ATDC5, C3H10T1/2 and HeLa cells. Data are
expressed as means (bars) ± SDs (error bars) of Relative Luciferase activity
for four assays/construct. (B) Endogenous Gdf5 mRNA expressions in
ATDC5 cells retrovirally transfected with the deletion mutants of SOX11.
mRNA levels were determined by quantitative RT-PCR and expressed as
means (bars) ± SDs (error bars) for 4 wells/construct.
Additional file 4: Figure S4. Luciferase assay for deletion of SOX family
binding site near the rs143383. Data are expressed as means (bars) ± SDs
(error bars) of Relative Luciferase activity for four assays/construct. *P <
0.05 vs.–448/+319 promoter. **P< 0.05 vs.–448/+319 promoter lacking
the +51/+75 region.
Additional file 5: Figure S5. Electromobility shift assay (EMSA) for
specific binding of the GDF5 promoter with human SOX11 protein. The
wild-type probe for segment A was used. (Detailed information is shown
in Figure 2). An open arrowhead indicates the shifted bands of the
SOX11-DNA probe complex, and a solid arrowhead indicates the band
supershifted by an antibody to SOX11. The supershift band is absent by a
non-immune normal IgG.
Additional file 6: Figure S6. Immunostaining with an antibody to
SOX11 in multiple regions of mouse knee joints. Red arrowheads indicate
positive signal for SOX11, while white arrowheads showed scarcity of
signal for SOX11. Immunostaining was detected by DAB, which was
followed by counterstaining with methyl green. mm: medial meniscus,
lm: lateral meniscus, ACL: anterior cruciate ligament.
Additional file 7: Figure S7. Immunostaining in the lateral
compartment of knee joints in osteoarthritis model of mice.
Immunostainings for SOX11 or GDF5 were detected by DAB, which was
followed by counterstaining with methyl green. Red arrowheads showed
positive signal for SOX11 or GDF5.
Additional file 8: Figure S8. Decrease of the SOX11 expression during
osteoarthritis progression. Safranin-O staining and immunostaining, with
an antibody to SOX11, of human knee cartilages. Other representative
samples are shown in Figure 5B. Cartilage degradation was evaluated by
the modified Mankin scoring system. Red arrowheads indicate positive
signal for SOX11. Scale bars, 500μm.
Additional file 9: Figure S9. Immunostaining, with an antibody to
SOX11 or non-immune normal IgG, of human cartilages. Immunostaining
was performed on human knee cartilage with a modified Mankin Score=2.
Additional file 10: Table 1. Primer sequences for plasmid
construction, shRNA or RT-PCR analysis used in this study.
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